Literature DB >> 35859679

What do I need to know about liraglutide (Saxenda), the glucagon-like peptide 1 receptor agonist for weight management in children with obesity?

Paul MacDaragh Ryan1, Jill K Hamilton1.   

Abstract

Entities:  

Keywords:  GLP-1RA; Liraglutide; Obesity; Saxenda

Year:  2022        PMID： 35859679      PMCID： PMC9291360          DOI： 10.1093/pch/pxac026

Source DB:  PubMed          Journal:  Paediatr Child Health        ISSN： 1205-7088            Impact factor:   2.600


× No keyword cloud information.
  8 in total

1.  Weighing risks and benefits of liraglutide--the FDA's review of a new antidiabetic therapy.

Authors:  Mary Parks; Curtis Rosebraugh
Journal:  N Engl J Med       Date:  2010-02-17       Impact factor: 91.245

Review 2.  Glucagon-like peptide 1 (GLP-1).

Authors:  T D Müller; B Finan; S R Bloom; D D'Alessio; D J Drucker; P R Flatt; A Fritsche; F Gribble; H J Grill; J F Habener; J J Holst; W Langhans; J J Meier; M A Nauck; D Perez-Tilve; A Pocai; F Reimann; D A Sandoval; T W Schwartz; R J Seeley; K Stemmer; M Tang-Christensen; S C Woods; R D DiMarchi; M H Tschöp
Journal:  Mol Metab       Date:  2019-09-30       Impact factor: 7.422

3.  Safety and Efficacy of Glucagon-Like Peptide-1 Receptor Agonists in Children and Adolescents with Obesity: A Meta-Analysis.

Authors:  Paul M Ryan; Sean Seltzer; Nathaniel E Hayward; David Avelar Rodriguez; Ryan T Sless; Colin P Hawkes
Journal:  J Pediatr       Date:  2021-05-11       Impact factor: 4.406

4.  The short half-life of glucagon-like peptide-1 in plasma does not reflect its long-lasting beneficial effects.

Authors:  Hongxiang Hui; Loredana Farilla; Patricia Merkel; Riccardo Perfetti
Journal:  Eur J Endocrinol       Date:  2002-06       Impact factor: 6.664

Review 5.  Gastrointestinal adverse events of glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a systematic review and network meta-analysis.

Authors:  Feng Sun; Sanbao Chai; Kai Yu; Xiaochi Quan; Zhirong Yang; Shanshan Wu; Yuan Zhang; Linong Ji; Jun Wang; Luwen Shi
Journal:  Diabetes Technol Ther       Date:  2015-01       Impact factor: 6.118

6.  Liraglutide combined with intense lifestyle modification in the management of obesity in adolescents.

Authors:  Louise J Apperley; Lucy Gait; Karen Erlandson-Parry; Peter Laing; Senthil Senniappan
Journal:  J Pediatr Endocrinol Metab       Date:  2021-04-07       Impact factor: 1.634

Review 7.  GLP-1 receptor agonists: an updated review of head-to-head clinical studies.

Authors:  Jennifer M Trujillo; Wesley Nuffer; Brooke A Smith
Journal:  Ther Adv Endocrinol Metab       Date:  2021-03-09       Impact factor: 3.565

8.  Distribution and characterisation of Glucagon-like peptide-1 receptor expressing cells in the mouse brain.

Authors:  Simon C Cork; James E Richards; Marie K Holt; Fiona M Gribble; Frank Reimann; Stefan Trapp
Journal:  Mol Metab       Date:  2015-08-05       Impact factor: 7.422
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.